Surface receptor and transporter protein down-regulation is assumed to be exclusively mediated by the canonical multivesicular body (MVB) pathway and ESCRTs (Endosomal Sorting Complexes Required for Transport). However, few surface proteins are known to require ESCRTs for down-regulation, and reports of ESCRT-independent degradation are emerging, suggesting that alternative pathways exist. Here, using Saccharomyces cerevisiae as a model, we show that the hexose transporter Hxt3 does not require ESCRTs for down-regulation conferring resistance to 2-deoxyglucose. This is consistent with GFP-tagged Hxt3 bypassing ESCRT-mediated entry into intralumenal vesicles at endosomes. Instead, Hxt3-GFP accumulates on vacuolar lysosome membranes and is sorted into an area that, upon fusion, is internalized as an intralumenal fragment (ILF) and degraded. Moreover, heat stress or cycloheximide trigger degradation of Hxt3-GFP and other surface transporter proteins (Itr1, Aqr1) by this ESCRT-independent process. How this ILF pathway compares to the MVB pathway and potentially contributes to physiology is discussed.
Surface polytopic proteins including receptors, transporters, and channels are internalized and sent to lysosomes for degradation1,2,3. Precise control of their surface levels underlies diverse physiology, including endocrine function, wound healing, tissue development, nutrient absorption, and synaptic plasticity2,4,5,6,7,8,9,10,11. Damaged surface proteins are also cleared by this mechanism to prevent proteotoxicity12,13,14. To trigger this process, surface proteins are labeled with ubiquitin—in response to changing substrate levels, heat stress to induce protein misfolding or cellular signaling for example—and then selectively internalized by the process of endocytosis13,15,16,17,18,19,20. Within the cell, they are sent to endosomes where they encounter ESCRTs (endosomal sorting complexes required for transport). These five protein complexes (ESCRT-0, -I, -II, -III, and the Vps4 complex) sort and package these internalized surface proteins into IntraLumenal Vesicles (ILVs)3. After many rounds, ILVs accumulate creating a mature multivesicular body (MVB)21,22. The MVB then fuses with lysosomes to expose protein laden ILVs to lumenal hydrolases for catabolism2.
Although many examples of ESCRT-mediated protein degradation have been published20, reports of ESCRT-independent degradation of surface proteins are emerging23,24,25,26,27. Furthermore, ILVs can be formed independent of ESCRT function and proteins recognized by ESCRTs continue to be degraded when ESCRTs are impaired28,29,30,31. These realizations have led to one of the most prominent open questions in our field: What accounts for ESCRT-independent ILV formation and surface protein degradation?
Around the time when ESCRTs were discovered32, Wickner, Merz and colleagues reported that an ILV-like structure called an intralumenal fragment (ILF) is formed as a byproduct of homotypic vacuolar lysosome (or vacuole) fusion in the model organism Saccharomyces cerevisiae33. Prior to lipid bilayer merger, fusogenic proteins and lipids concentrate within a ring at the vertex between apposing vacuole membranes34,35. Upon SNARE (Soluble NSF [N-ethylmaleimide-sensitive factor] Associated protein REceptor)-mediated membrane fusion at the vertex ring, the encircled area of membrane, called the boundary, is excised and internalized within the lumen of the fusion product where it encounters acid hydrolases36.
We recently discovered that vacuolar polytopic proteins, e.g., ion and nutrient transporters, are selectively sorted into the boundary membrane for degradation in response to substrate levels, misfolding by heat stress or TOR (Target Of Rapamycin) signaling triggered by cycloheximide37. Named the ILF pathway, this process functions independently of ESCRTs and instead relies on the fusion protein machinery for transporter sorting and ILF formation. This process performs similar functions as ESCRTs, except the mechanisms underlying protein sorting and packaging are distinct. Thus, the possibility exists that surface polytopic proteins may also be degraded by the ILF pathway if they can be delivered to the vacuole membrane after internalization.
Can internalized surface proteins be delivered to vacuole membranes? To our knowledge, this hypothesis has not been formally tested. However, this proposition seems reasonable when considering the consequence of bypassing ESCRT function in the canonical MVB pathway (Fig. 1a). In theory, any internalized surface polytopic protein that is not packaged into ILVs by ESCRTs (or returned to the surface) remains embedded within the outer membrane of the mature MVB. When this membrane merges with the vacuole membrane upon heterotypic fusion, these proteins are then exposed to the ILF machinery, which may package them for degradation. Thus, by simply avoiding recognition by ESCRTs, internalized surface proteins are, by default, delivered to vacuole membranes and the ILF pathway.
Upon reexamination of micrographs presented in earlier reports on receptor and transporter down-regulation, we found that some internalized surface polytopic proteins appear on vacuole membranes on route to the lumen for degradation, e.g., the high-affinity tryptophan permease Tat238, peptide transporter Ptr239, myo-inositol transporter Itr140, and glucose transporters Hxt1 and Hxt341. We also noticed that most of these published studies do not directly assess whether ESCRTs are required for protein degradation. Given that internalized surface transporters and receptors can appear on vacuole membranes, we decided to test the hypothesis that the ILF pathway represents an alternative, ESCRT-independent mechanism for degradation of surface polytopic proteins (Fig. 1a).
ESCRTs are not required for 2-deoxyglucose resistance
ESCRTs have been implicated in the down-regulation of surface transporters required for S. cerevisiae cell survival and proliferation in the presence of toxic substrates. For example, to prevent entry of the toxic arginine analog canavanine, the surface arginine permease Can1 is endocytosed and sorted for degradation by ESCRTs17. Similarly, the surface glucose transporter Hxt3 is internalized and degraded in the presence of 2-deoxyglucose, a toxic glucose analog41. It has been proposed that deleting ESCRTs blocks delivery to vacuoles and subsequent degradation of these transporters, causing them to accumulate in aberrant endosomal structures. Here they can be returned to the plasma membrane by a Snx3-dependent retrograde trafficking pathway, allowing toxin entry17. Thus, based on this model, deletion of ESCRT genes should reduce cell viability in the presence of canavanine or 2-deoxyglucose.
We tested this hypothesis by treating yeast cultures with increasing concentrations of either toxin and then assessed effects on cell viability by imaging and counting dead yeast cells stained with methylene blue (Fig. 1b). As expected, deleting components of ESCRT-0 (VPS27) or ESCRT-II (VPS36)—to disrupt different early- or late-acting complexes, respectively, necessary for protein sorting into ILVs—enhanced sensitivity to the toxin canavanine. However, deleting these ESCRT genes had no effect on cell viability in the presence of 2-deoxyglucose. As controls, we examined cells lacking CAN1 or HXT3 and found that they were resistant to canavanine or 2-deoxyglucose, respectively, as predicted. Thus, these data suggest that ESCRTs mediate degradation of Can1 but may not be required for Hxt3 degradation triggered by 2-deoxyglucose.
Hxt3 protein degradation is ESCRT-independent
Based on micrographs presented in previous reports showing Hxt3 on vacuole membranes41, we first assessed the possibility that internalized Hxt3 bypassed ESCRTs altogether at the endosome and instead were delivered to vacuole membranes where it may be sorted for degradation. To test this hypothesis, we used fluorescence microscopy to monitor the distribution of GFP-tagged Hxt3 in live S. cerevisiae cells over time after addition of 2-deoxyglucose (Fig. 1c). As predicted, Hxt3-GFP is exclusively found on the plasma membrane before treatment. After addition of 2-deoxyglucose, it first appears on puncta (representing endosomes; at 5 min) and later on vacuole membranes stained with FM4–64 (30 min; Fig. 1d). Finally, Hxt3-GFP accumulates within the vacuole 60–120 min after treatment. We assessed all cells imaged, quantified these observations (Fig. 1e) and confirmed that Hxt3-GFP was progressively cleared from the plasma membrane while accumulating in puncta, on the vacuole membrane and in the vacuole lumen over time after 2-deoxyglucose addition. In contrast, internalized Can1-GFP, an ESCRT-client, never appears on vacuole membranes on route to the vacuole lumen for degradation when cells were treated with canavanine (Fig. 1c–e), as predicted for the canonical MVB pathway. To confirm that proteolysis occurs, we conducted western blot analysis to detect cleavage of GFP from Hxt3 or Can1 in whole-cell lysates (Fig. 1f). As predicted, we found that more GFP was cleaved over time correlating with toxin triggered downregulation of these transporters regardless of route taken to the vacuole lumen.
In all, these findings suggest that internalized Hxt3-GFP bypasses ESCRT function at endosomes, and instead is delivered to vacuole membranes on route to the lumen where it is degraded in response to 2-deoxyglucose. If true, then deleting ESCRT genes should have no effect on this process. To test this hypothesis, we tracked the subcellular distribution of Hxt3-GFP after 2-deoxyglucose treatment in cells lacking the ESCRT gene VPS36 (Fig. 1c–e). Although Hxt3-GFP continues to be delivered to the vacuole lumen over time, we noticed that on route, Hxt3-GFP abnormally accumulated on puncta and vacuole membranes, even prior to treatment, in mutant cells. This is consistent with previous reports showing that deleting ESCRT genes impairs, but does not entirely block, endocytosis and delivery of vacuole cargo proteins in addition to completely abolishing protein sorting into ILVs3. Importantly, GFP continued to be cleaved from Hxt3 (Fig. 1f) confirming that it continues to be degraded in absence of VPS36. Thus, delivery of internalized Hxt3-GFP to the vacuole lumen for degradation in response to 2-deoxyglucose does not require ESCRTs.
2-deoxyglucose triggers Hxt3 degradation by ILF pathway
What mediates ESCRT-independent Hxt3-GFP degradation? Because this surface polytopic proteins appear on the vacuole membrane, we reasoned that this is where it is sorted and packaged into intralumenal vesicles or fragments for degradation. Although microautophagy may be responsible, no intermediate structures resembling elongated invaginations extending into the vacuole lumen were observed42 and there are no reports of selective protein sorting associated with this process (rather these structures seem to be devoid of membrane proteins42). Instead, we considered two processes reported to mediate selective degradation of vacuole membrane proteins: the ESCRT-dependent vReD (vacuole membrane Recycling and Degradation) pathway43 and ESCRT-independent ILF pathway37. Given that ESCRTs were not required for Hxt3-GFP down-regulation, we eliminated the possibility that the vReD pathway was responsible and focused on the ILF pathway.
Upon further examination of micrographs showing Hxt3-GFP distributed on vacuole membranes after toxin addition, we found that it was present within boundary membranes between docked vacuoles, the area of membrane that is internalized as an ILF and degraded upon fusion (Fig. 2a, b). To confirm, we measured the GFP fluorescence within the vacuole boundary membranes in the cell population (Fig. 2c). To determine if Hxt3-GFP was getting sorted into the boundary, we compared its distribution to three GFP-tagged ILF-client proteins that are residents of the vacuole membrane: Fet5 (a copper oxidase) which is known to be excluded from boundaries, Vph1 (the stalk domain of the V-type H+-ATPase) which is distributed uniformly on vacuole membranes, and Fth1 (an iron transporter) which is enriched in boundaries (Fig. 2b–d; see ref. 37). From this analysis, it was clear that the Hxt3-GFP boundary profile was most similar to Fth1-GFP (Fig. 2b, c), suggesting that it was enriched and thus possibly sorted into the ILF pathway.
We also found that the distribution of these three GFP-tagged resident vacuole proteins was unaffected by 2-deoxyglucose (Fig. 2d), suggesting that their turnover was not stimulated by this toxin. Similarly, 2-deoxyglucose does not trigger downregulation of GFP-tagged Can1 or the surface myo-inositol transporter Itr1 (Fig. 2d). Moreover, Hxt3-GFP was not down-regulated when cells were treated with canavanine (Fig. 2a). We assessed all cells imaged, quantified these observations and confirmed that only Hxt3-GFP was downregulated by 2-deoxyglucose but it was unaffected by canavanine (Fig. 2e). These important findings imply that Hxt3-GFP was selectively sorted into the ILF pathway in response to only its cognate toxic substrate 2-deoxyglucose.
Finally, to demonstrate that Hxt3-GFP was internalized into the lumen during fusion we recorded homotypic vacuole membrane fusion events in live cells treated with 2-deoxyglucose, and confirmed that Hxt3-GFP decorated ILFs created by fusion events (Fig. 2f; Supplementary Movie 1). Homotypic vacuole fusion was not stimulated by 2-deoxyglucose, as we counted the same number of fusion events within cells in the absence (CTL) and presence of the toxin (Fig. 2g). Thus, vacuole fusion persists under these conditions and seems to mediate the selective degradation of Hxt3 after endocytosis.
Together, these observations led us to conclude that Hxt3 avoids ESCRTs and is instead selectively sorted for degradation by the ILF pathway. Two questions immediately arose after making this exciting discovery: Is surface protein degradation by the ILF pathway only triggered by toxic substrates, or does it contribute to other triggers of surface transporter down-regulation? Is the ILF pathway responsible for degradation of other surface polytopic proteins? In other words, how pervasive is the contribution of the ESCRT-independent ILF pathway to surface transporter and receptor protein downregulation?
ILF pathway degrades Hxt3 in response to diverse stimuli
When yeast cells are challenged with acute heat stress, surface polytopic proteins are thought to misfold, which disrupts their function and contributes to membrane permeabilization preceding cell death. If they cannot be refolded (through the activity of chaperones), they are internalized and sent to the vacuole lumen for degradation—presumably by the MVB pathway—to mediate surface polytopic protein quality control20.
Thus, to answer the first question, we tested whether treating cells with heat stress also triggers Hxt3-GFP degradation by the ILF pathway using fluorescence microscopy to monitor its distribution within living cells. As with 2-deoxyglucose, we found that Hxt3-GFP is internalized from the surface after heat stress and accumulates on vacuole membranes (Fig. 3a, b) within boundaries between docked organelles (Fig. 3a, c) and in the vacuole lumen (Fig. 3d). We confirmed that Hxt3-GFP decorated ILFs formed during homotypic vacuole fusion events in live cells (Fig. 3e; Supplementary Movie 2), which correlated with enhanced Hxt3-GFP degradation as assessed by western blot analysis of whole-cell lysates (Fig. 3f). Similar observations were made when we applied cycloheximide (Fig. 4; Supplementary Movie 3), a trigger of TOR (Target Of Rapamycin) signaling, an important mediator of cell growth and metabolism44, that stimulates surface protein degradation17 and the ILF pathway37. Deleting VPS36 had no effect on Hxt3-GFP clearance from plasma membranes, delivery to vacuole boundary membranes, internalization during homotypic vacuole fusion or protein degradation in response to heat stress (Fig. 3; Supplementary Movie 4) or cycloheximide (Fig. 4; Supplementary Movie 5), confirming that this process is ESCRT-independent. Thus, we concluded that the ILF pathway mediates Hxt3 protein quality control and degrades this transporter protein in response to cycloheximide.
ILF pathway machinery mediates Hxt3-GFP degradation in vitro
To verify that the observed degradation of internalized Hxt3-GFP was conducted by the ILF pathway machinery, we repeated experiments using in vitro fusion reactions containing isolated vacuoles based on the following reasoning [see 37]: (1) all molecular machinery underlying the ILF pathway copurifies with vacuoles, in a preparation that excludes possible cytoplasmic contributors to Hxt3-GFP degradation (e.g., the proteasome) as well as the protein translation machinery to eliminate interference by biosynthesis. (2) activation of the Rab GTPase Ypt7 is critical for sorting proteins into the ILF pathway. However, deleting YPT7 chronically blocks all vacuole fusion events including MVB-vacuole fusion preventing study of the ILF and MVB pathways in live cells. Instead, purified protein inhibitors of Ypt7–rGdi1 (a Rab-GTPase chaperone protein that extracts Ypt7 from membranes) and rGyp1-46 (the catalytic domain of the Rab GTPase activating protein Gyp1 that inactivates Ypt745) can be added to in vitro vacuole fusion reactions containing healthy organelles to acutely block Ypt7 permitting study of protein sorting into ILFs. Thus, if the ILF machinery is responsible for Hxt3-GFP degradation, then it should continue to occur in vitro and be sensitive to Ypt7 inhibitors.
To test this hypothesis, we first isolated vacuoles from untreated wild-type cells, imaged them and found that Hxt3-GFP decorated their membranes (Fig. 5a). Further investigation revealed that surface Hxt3-GFP is down-regulated in live yeast cells during the organelle isolation procedure (e.g., during spheroplasting when their cell walls are enzymatically removed; Fig. 5a). We made a similar observation when live cells were withdrawn from glucose for 5 min in growth medium (Fig. 5a), a novel trigger of Hxt3-GFP degradation. All solutions for the organelle isolation procedure are devoid of glucose. Thus, we reasoned that glucose depletion during vacuole purification triggers Hxt3-GFP downregulation, accounting for its presence on vacuole membranes and within the lumen in vitro.
Next, we added ATP to isolated vacuoles to initiate homotypic fusion in vitro and imaged reactions 30 min afterwards (Fig. 5b). As expected, we found that Hxt3-GFP was present in boundary membranes (Fig. 5c) and within the vacuole lumen (Fig. 5d). Consistent with these findings, we found that more Hxt3-GFP was degraded after fusion by western blot analysis (Fig. 5e). However, we noted that relative high levels of cleaved GFP were found in all preparations containing isolated vacuoles, including those analyzed prior to fusion (0 min). It is possible that vacuole rupture and release of lumenal proteases may account for this observation. Although we cannot completely eliminate this possibility, we argue that it is unlikely because protease inhibitors are present in the fusion reaction buffer and should block all extra-lumenal proteolysis. Moreover, this observation is consistent with surface Hxt3-GFP being endocytosed and delivered to the membrane and lumen of vacuoles during the isolation procedure, prior to fusion in vitro (see Fig. 5a). This step of the procedure requires 60 min, which may explain why band patterns look similar to those observed at 60 min after 2-deoxyglucose treatment in vivo (Fig. 1f). This also explains why relatively high levels of lumenal GFP fluorescence (~60% of total) are observed in vacuole preparations prior to fusion (Fig. 6b). Thus, we are confident that the observed changes in GFP-cleavage reflect lumenal Hxt3-GFP degradation that correlates with internalization during vacuole fusion, suggesting that the ILF pathway mediates Hxt3-GFP degradation in vitro.
Importantly, both heat stress and CHX significantly increased the amount of Hxt3-GFP present in the boundary (Fig. 5b, c), internalized (Fig. 5d) and degraded (Fig. 5e) by the ILF pathway in vitro. We made similar observations when experiments were repeated with vacuoles isolated from vps36∆ cells (Fig. 5b–e), confirming that ESCRTs are not required for protein sorting. However, these responses were not as robust as those observed in vivo (see Figs. 3 and 4). We reasoned that this is because Hxt3-GFP found on isolated vacuole membranes is already marked for degradation, as its presence is the product of downregulation presumably triggered by glucose withdrawal during the organelle isolation procedure (Fig. 5a) and it is degraded during fusion in vitro under control (unstimulated) conditions (Fig. 5b–e). Thus, heat stress or CHX further enhances clearance of Hxt3-GFP that is already destined for degradation. Because these responses are additive, we reasoned that heat stress and CHX likely target distinct mechanisms, at least in part, from those that respond to glucose withdrawal. Because heat stress and CHX trigger Hxt3-GFP degradation in vitro, the underlying machinery must be present on vacuole membranes, whereas the machinery that senses glucose withdrawal must be, in part, present on the plasma membrane to accommodate endocytosis, and neither likely include ESCRTs.
Next, we pretreated in vitro vacuole fusion reactions with Ypt7 inhibitors and found that they blocked Hxt3-GFP sorting, internalization and degradation (Fig. 5b–e), implicating Ypt7 and its effectors in Hxt3-GFP sorting into boundary membranes. However, closer examination of western blots revealed that some residual Hxt3-GFP cleavage occurred in the presence of inhibitors under all conditions tested (Fig. 5e; compare 0–120 min with fusion inhibitors). One explanation is that perhaps some vacuoles were docked, and contained Hxt3-GFP in their boundary membranes, upon isolation (i.e., they were engaged in the fusion process in live cells before lysis). If so, then Ypt7 inhibitors would be unable to block subsequent Ypt7-independent stages of fusion responsible for Hxt3-GFP internalization and degradation, accounting for the observed residual GFP-cleavage. This also accounts for the small fraction of the vacuole population that contains relatively high levels of Hxt3-GFP fluorescence in the boundary and lumen in the presence of Ypt7 inhibitors (Fig. 5c, d). Thus, all things considered, we are confident that Ypt7 and the ILF pathway machinery located on the vacuole membrane is likely responsible for Hxt3-GFP degradation triggered by diverse stimuli.
Clearance of ESCRT-client proteins from endosome membranes is thought to require multiple rounds of ILV formation3, raising the question: How efficient is protein clearance from vacuole membranes by the ILF pathway? To answer it, we initiated homotypic vacuole fusion in vitro with ATP and imaged reactions every 30 min over 2 h (Fig. 6a). Some GFP fluorescence was observed in the vacuole lumen prior to fusion (0 min) and this signal increased over the course of the fusion reaction (Fig. 6b). Moreover, the amount of Hxt3-GFP on vacuole membranes decreased over time (Fig. 6c), confirming that this transporter was getting internalized into the lumen during the fusion reaction. Similar observations were made after isolated vacuole were subjected to heat stress prior to initiation of fusion (Fig. 6a–c), except the effect was more pronounced whereby nearly all of Hxt3-GFP on the membrane was internalized into the lumen after 120 min (also see Fig. 6d), consistent with complete degradation observed by western blot analysis (Fig. 5e). Previously, we showed that heat stress has no effect on the rate of vacuole fusion in vitro37 and it is known that the population of isolated vacuoles undergoes 1.5 fusion events after 120 min under these conditions46. Thus, we estimate that Hxt3-GFP can be completely cleared from vacuole membranes within two fusion events.
ILF pathway mediates quality control of many surface proteins
Is the ILF pathway responsible for downregulation of other surface transporter proteins? To answer this (second) question, we used fluorescence microscopy to screen for other ILF-client proteins by examining the intracellular membrane distribution of GFP-tagged surface transporter or receptor proteins after live cells were challenged with heat stress, which should trigger degradation of all surface polytopic proteins. Five surface proteins showed clear phenotypes: Unlike Can1, Ste3 (a G-protein coupled receptor) or Mup1 (a methionine permease [see 47]), internalized GFP-tagged Itr1 (a myo-inositol transporter)40 and Aqr1 (a major facilitator superfamily-type transporter that excretes amino acids)48 appeared on vacuole membranes on route to the vacuole lumen for degradation (Fig. 7a, c). Both transporters were present within boundary membranes between organelles (Fig. 7b) and accumulated in the vacuole lumen of live wild type cells after heat stress (Fig. 7d). This correlated with enhanced Itr1-GFP and Aqr1-GFP degradation after heat stress as assessed by western blot analysis of whole-cell lysates (Fig. 7e). Importantly, deleting VPS27, a component of ESCRT-0, had no effect on the, internalization, sorting or degradation of Itr1-GFP or Aqr1-GFP after heat stress (Fig. 7a–e), confirming that the ESCRT-independent ILF pathway is critical for quality control of these transporter proteins. Thus, the ILF pathway mediated degradation of three of six proteins examined, suggesting that it may play a considerable role in surface transporter protein downregulation.
Here we demonstrate that whereas some internalized surface polytopic proteins (Can1) rely on the canonical ESCRT-dependent MVB pathway for downregulation, other presumed ESCRT-client proteins (Hxt3, Itr1, Aqr1) bypass ESCRT function at endosomes and, upon MVB-vacuole fusion, are delivered to vacuole membranes where they are selectively sorted for degradation by the ILF pathway (see Fig. 1a). Both pathways are triggered by the presence of toxic substrates, substrate withdrawal or cycloheximide and are critical for protein quality control. Thus, the assumption that all surface proteins are degraded by the MVB pathway is no longer reasonable, and we speculate that the ILF pathway may play an equally important role in surface polytopic protein downregulation. This conclusion raises many new questions concerning this important area of fundamental cell biology: What evidence supports ESCRT-mediated protein down-regulation? What distinguishes one pathway from the other? What determines protein entry into each pathway? What is the potential impact of this discovery on eukaryotic physiology?
Herein, we reveal that internalized surface polytopic proteins may take two distinct pathways to the vacuole lumen for degradation. Paramount to this discovery was visualizing internalized surface receptors within live cells over time to track their routes to the vacuole lumen for degradation (e.g., Figure 1c). This revealed that some internalized proteins accumulate on the vacuole membrane: a trafficking intermediate that does not occur in the MVB pathway, but is a requirement for the ILF pathway. Unfortunately, the majority of previous reports on surface protein degradation do not provide such detailed kinetic analyses and instead present only light micrographs of cells before and after treatment, indicating surface and vacuole lumen protein distributions respectively13,14,41,49,50,51,52. Many important papers originally describing degradation of surface receptors or transporters do not include any micrographs53. Thus, the pathway responsible for their degradation now seems enigmatic. Moreover, when comprehensive datasets are provided, many internalized surface transporters appear on vacuole membranes38, suggesting that ILF-dependent degradation of surface proteins may be widespread.
Further confounding this issue is that protein sorting and ILV formation by ESCRTs cannot be accurately visualized in biological systems using light microscopy due to limitations of spatial resolution. Rather, samples must be fixed and imaged using electron microscopy coupled with immune-gold labeling. Due to associated technical challenges, very few reports provide electron micrographs to definitively demonstrate protein sorting or internalization by ESCRTs54,55,56. However, for the ILF pathway, here we show surface transporters being delivered to the lumen during homotypic vacuole fusion in real time within live cells using HILO microscopy (Figs. 2f, 3e, and 4e; Supplementary Movies 1–5). In addition to providing definitive proof that the ILF pathway contributes to degradation of these transporters, this approach (including FRAP37) offers the advantage of allowing us to study the fundamental properties of protein sorting for transporter and receptor downregulation.
Finally, although we present data from complimentary experimental approaches to support our conclusions, we recognize that both pathways rely on the same membrane trafficking route within cells, i.e. endocytosis culminating with MVB-vacuole fusion (see Fig. 1a). As such, we expect that genetic manipulations affecting both pathways will cause pleiotropic phenotypes. For example, in addition to blocking ILV formation, deleting ESCRT genes partially inhibits MVB-vacuole fusion57, which is required to deliver internalized proteins to the ILF pathway, and prevents efficient delivery of some biosynthetic cargoes to the vacuole lumen (e.g., carboxypeptidase S and other vacuole hydrolases)3. This perhaps explains why Hxt3-GFP accumulates on puncta and the vacuole membrane in vps36∆ cells (e.g., Fig. 1c–e) and its degradation profile is different than in wild-type cells (Figs. 1f, 3f, 4f, 5e, and 7e). If true, then appearance of internalized proteins on these aberrant structures in ESCRT knockout cells is not a phenotype exclusive to ESCRT-client proteins, warranting reevaluation of published data that relies on this phenotype to infer protein degradation by the MVB pathway. All things considered, we provide a logical framework to determine which pathway mediates surface protein degradation and are currently conducting screens to comprehensively understand the contributions of each to surface receptor and transporter down-regulation in S. cerevisiae.
From a mechanistic perspective, both pathways are processes that share four general stages required for selective protein degradation:3,37 (1, labeling) The protein must be labeled for degradation. (2, sorting) Labeled proteins must be selectively sorted into an area of membrane that is (3, internalization) internalized as a vesicle (or membrane fragment) into the lumen of an endocytic organelle. (4, degradation) Protein-laden lumenal vesicles must be exposed to vacuolar hydrolases for catabolism. Given these functional similarities, we argue that the underlying molecular machinery must, in part, be shared by both pathways. However, it must also differ to account for their distinctions.
Although little is known about protein labeling in the ILF pathway, we propose that the underlying mechanisms are likely shared with the MVB pathway, which employs protein ubiquitylation as a label for selective degradation58. This is based on the following reasoning: (1) prior to this work, Hxt3, Itr1 and Aqr1 were reported to be ubiquitylated by specific E3-ligase and E4-adapter proteins in response to the same stimuli that drive their downregulation by the ILF pathway (e.g., Rsp5 and Art5, respectively, for Itr1)40. 2 The same ubiquitylation machinery labels polytopic proteins at the plasma membrane, endosome membranes, and vacuole membranes (e.g., E3 ligases Rsp5 and Pib1, and E4 adapter Ssh4)40,43,59. This possibly explains why heat stress triggers degradation of Hxt3-GFP on isolated vacuole membranes in vitro (Figs. 5 and 6), as is does for Hxt3-GFP on the plasma membrane in live cells (Figs. 3 and 7). 3 When ESCRT genes are deleted, ESCRT-client proteins Can1, Ste3, and Mup1 continue to be degraded, albeit less efficiently, by the ILF pathway47, suggesting that the machinery underlying sorting in each pathway recognizes a common label. Furthermore, the ubiquitylation machinery mediates selective soluble protein degradation by other cellular pathways (e.g., Rsp5, Ydj1, and the proteasome)60. Sharing the same sensing and labeling machinery permits harmonization of protein degradation pathways, including the ILF and MVB pathways, for coordinated compartmental changes in proteostasis needed for a global cellular response to a single stimulus and this redundancy also ensures toxic proteins are destroyed.
It is clear from this study that the mechanisms underlying protein sorting into each pathway are distinct: ESCRTs drive sorting in the MVB pathway3,58, an unknown, ESCRT-independent mechanism that requires Rab-GTPase activation is important for sorting in the ILF pathway (Fig. 5) [see 37]. Location of the sorting machinery is not likely critical, as ESCRTs are found on endosome and vacuole membranes43, and the machinery thought to underlie protein sorting into ILFs is present on endosome and vacuole membranes where they drive fusion events (e.g., Ypt7)57,61. The mechanisms underlying internalization are distinct as well: In the MVB pathway, labeled proteins are internalized by ILV formation culminating with lipid bilayer scission by ESCRT-III and the Vps4-Vta1 complex on the endosome membrane62. Whereas, labeled proteins are internalized by ILF formation during bilayer fusion by fusogenic proteins (SNAREs) and lipids concentrated at the vertex ring formed between two docked vacuoles33,34,35,37. Finally, the mechanisms underlying degradation are essentially shared as the outcomes of both processes are equal: polytopic proteins embedded in membrane vesicles (or fragments) are degraded by acid hydrolases with the vacuole lumen3,37.
In terms of efficiency, each ILV generated by ESCRTs has an estimated membrane area of 0.03µm2 (assuming it is spherical with a radius of 0.05 µm63) whereas each ILF generated by a vacuole fusion event has an area up to 2.26 µm2 (assuming it is a double boundary membrane disk with a radius of 0.6µm, average vacuole radius of 1.0 µm, and all of the boundary membrane is internalized)36. Thus, membrane internalized by a single ILF is equivalent to 75 ILVs. Given that each MVB contains approximately 30 ILVs63, at least three MVB-vacuole fusion events are necessary to deliver the same amount of protein-laden membrane to the vacuole lumen as a ILF produced by one vacuole fusion event. Herein, we also show that nearly all Hxt3-GFP is cleared from vacuole membranes by the ILF pathway within two rounds of vacuole fusion in vitro (Fig. 6). In live cells, individual vacuole fusion events require 30–60 s (e.g., Fig. 2f and Supplementary Movie 1) under conditions that promote Hxt3-GFP enrichment within boundary membranes (Fig. 2c). Endocytosis can occur within min64. Thus, when considering the capacity and kinetics of this process, it is easy to envision how the ILF pathway can completely down-regulate Hxt3 in as little as 5 min, as observed after glucose withdrawal (Fig. 5a). Furthermore, this possibly accounts for faster delivery of the ILF-client Hxt3-GFP from the surface to the vacuole lumen as compared to the ESCRT-client Can1-GFP observed in response to their cognate toxins within live cells (Fig. 1e). In all, it seems that the ILF pathway offers the cell a relatively high-capacity solution for rapid surface polytopic protein degradation.
Surface receptor and transporter protein downregulation is critical for diverse physiology in all eukaryotes. ESCRT-dependence has been demonstrated for only a handful of human receptors and transporters. These represent a miniscule fraction of an estimated ~5500 polytopic proteins encoded by the human genome65, all of which presumably have finite lifetimes and must be selectively degraded. Thus, for the subset that represents surface polytopic proteins, it is reasonable to propose that this burden is split by at least two pathways. For example, here we discovered that the ILF pathway mediates downregulation of the yeast hexose transporter (Hxt3) when glucose is withdrawn from the growth medium (Fig. 5a). Downregulation of orthologous glucose transporters (e.g., GLUT4) triggered by glucose depletion is observed in mammalian epithelial cells lining the ileum or proximal tubule of the nephron66,67,68, but it is not clear what mediates this process, which is needed for sugar (re)absorption. Genes encoding the proposed machinery underlying the ILF pathway are conserved in all eukaryotes including humans69, like genes encoding ESCRTs3. Thus, it is tempting to speculate that the ILF pathway also contributes to the down-regulation of these sugar transporters, as well as other receptors and transporters, in mammalian cells.
Why two pathways? Evolutionary theory predicts that each pathway must perform a distinct, fundamental function necessary for eukaryotic physiology to be conserved. The concept of two pathways for surface polytopic protein down-regulation is obviously still in its infancy, but in support, we offer three speculative explanations for their coexistence: (1) whereas, the function of ESCRT clients, such as Can1, may be unnecessary or not tolerated on vacuole membranes, ILF-client proteins may function on vacuoles (or lysosomes) as well as on the plasma membrane. However, this is unlikely for Hxt3 because after it is endocytosed, it concentrates in boundary membranes (Figs. 2c, 3c, 4c, and 5c) and is efficiently cleared from vacuole membranes (see Fig. 6). (2) Unlike ILF clients, ESCRT-client proteins may require immediate sequestration from the cytoplasm after endocytosis. For example, activated hormone receptors must be sequestered into ILVs for accurate signal termination8. (3) ESCRT clients are can be reused either by ILV back fusion, i.e., membrane fusion between ILV and MVB perimeter membranes (although this is contentious) or by MVB-plasma membrane fusion which releases protein-laden ILVs as exosomes8. Whereas degradation is certain for ILF-client proteins.
In addition to their role in the MVB pathway, ESCRTs are recruited to other compartmental membranes where they make important contributions to cytokinesis, reformation of the nuclear envelope, and exosome release—process that terminate with membrane fission70,71. Orthologous components of the ILF machinery (e.g., CORVET) are present on other endosomal compartments where it drives fusion events needed for membrane trafficking as well as organelle biogenesis and homeostasis61,69. Thus, from a broader perspective, it seems that ESCRTs drive membrane remodeling prior to fission, whereas the components of the ILF pathway remodel membranes prior to fusion within eukaryotic cells. Through these different mechanisms, we speculate that the ILF pathway plays a distinct but equally important role as the MVB pathway in surface transporter and receptor downregulation.
Yeast strains and reagents
All Saccharomyces cerevisiae strains used in this study are listed in Table 1. All unique yeast strains generated for this study are available from the authors. To knock out VPS27 by homologous recombination we used the Longtine method72 and the following primers: (forward; CBO202) 5′-GCTAAGGTGAATGAGTAGTGAGTAAAGAACTAAGAACAGTCGGAT CCCCGGGTTAATTAA-3′ and (reverse; CBO203) 5′-CTAGGTTCCTTTTTACAAATACATAG AAAAGGCTACAATAGAATTCGAGCTCGTTTAAAC-3′; and extended the homologous regions of genomic DNA (underlined) covering 80 base pairs to improve targeting and integration using the following primer set: (forward; CBO204) 5′-TAGAGGGTGTAAAATTATCAAG ATTTTTTTTTGCTAAGGTGAATGAGTAGTC-3′ and (reverse; CBO205) 5′-CAAGCAATTATATA TATATGTATGTATATATTTATAAGCGCTAGGTTTCTTTTTACAAAT-3′. To knockout VPS36, we used the same approach with the following primer sets: (forward, CBO594) 5′-AGGAAGTG TGTTTTGAAAGTCATTCTTTTTTTTTCAAAAGCGGATCCCCGGGTTAATTAA-3′ and (reverse; CBO596) 5′-ATGTAGTATTACGAGCAGGTAATCAAACCATGCATTTATTGAATTCGAGCTCGTT TAAAC-3′, as well as (forward, CBO595) 5′-AGGTCATCCAAGATAGAATAGGGGACC TCGGCTAGGAATCAGGAAGTGTGTTTTGAAAGT-3′ and (reverse; CBO597) 5′-TTTAGCC GCGCGTTTATATGTAAACTATTTATTTGGGAGAATGTAGTATTACGAGCAGGT-3′. Genomic mutations were confirmed by PCR and sequencing.
Biochemical and yeast growth reagents were purchased from either Sigma-Aldrich, Invitrogen, or BioShop Canada Inc. Proteins used include recombinant Gdi1 purified from bacterial cells using a calmodulin-binding peptide intein fusion system73 and recombinant Gyp1–46 (the catalytic domain of the Rab-GTPase activating protein Gyp1) purified as previously described74. Reagents used in fusion reactions were prepared in 20 mM Pipes-KOH, pH 6.8, and 200 mM sorbitol (Pipes Sorbitol buffer, PS).
Yeast cell viability assay
To assess cell viability, yeast were cultured in SC medium for 16–18 h, pelleted, and resuspended in fresh SC medium. Cells were then treated with 0, 0.2 or 2 mM 2-deoxyglucose and incubated at 30 °C for 2 h, or with 0, 37, or 340.6 µM canavanine and incubated at 30 °C for 8 h. After incubation, cells were washed once with SC medium, resuspended in 100 µL SC containing 0.1% (w/v) methylene blue and incubated at room temperature for 5 min prior to imaging. Micrographs were acquired using a Nikon Eclipse TiE inverted epifluorescence microscope equipped with a Nikon DsRi2 high resolution (4908 × 3264 pixels) color CMOS (Complementary Metal-Oxide Semiconductor) camera, a Nikon CFI × 40 Plan Apo Lambda 0.95 NA objective lens and DIC optics. Methylene blue positive (MB + ) and unstained cells were counted manually using ImageJ software (National Institutes of Health, USA).
Highly inclined laminated optical sheet (HILO) microscopy
Micrographs were acquired using a Nikon Eclipse TiE inverted microscope equipped with a motorized TIRF (Total Internal Reflection Fluorescence) illumination unit, Photometrics Evolve 512 EMCCD (Electron Multiplying Charge Coupled Device) camera, Nikon CFI ApoTIRF 1.49 NA ×100 objective lens, and 488 nm or 561 nm 50 mW solid-state lasers operated with Nikon Elements software. Cross sectional images were recorded 1 μm into the sample.
Live cell imaging
Live yeast cells were stained with FM4–64 to label vacuole membranes using a pulse-chase method as previously described45. To trigger downregulation of GFP-tagged surface polytopic proteins, cells in SC medium were either treated with 0.2 mM 2-deoxyglucose (Sigma-Aldrich) for up to 120 min at 30 °C, 340.6 μM canavanine (Sigma-Aldrich) for up to 8 h at 30 °C, 100 μM cycloheximide for 90 min at 30 °C, resuspended in SC medium without d-glucose for 5 min at 30 °˚C, or incubated at 37 °C for 15 min for heat stress. After treatments, cells were washed and resuspended in SC medium at 30 °C prior to imaging by HILO microscopy. Time-lapse videos were acquired for 5 min at 30 °C using a Chamlide TC-N incubator (Live Cell Instruments) with cells plated on coverslips coated with concavalin-A (1 mg/mL in 50 mM HEPES, pH 7.5, 20 mM calcium acetate, 1 mM MnSO4).
Vacuole isolation and homotypic vacuole fusion
Vacuoles were purified from yeast cells as previously described75, whereby cells were harvested, washed, treated with oxalyticase to generate spheroplasts (shown Fig. 5a), gently permeabilized using DEAE-dextran (also shown in Fig. 5a) and then organelles were separated on a ficoll gradient by ultracentrifugation (100,000 × g, 90 min, 4 °C). Homotypic vacuole fusion reactions were prepared using 6 μg of isolated vacuoles in standard fusion reaction buffer with 0.125 M KCl, 5 mM MgCl2, and 10 μM CoA. 1 mM ATP was added to trigger fusion. Vacuolar membranes were stained with 3 μM FM4–64 for 10 min at 27 °C. Reactions were incubated at 27 °˚C for up to 120 min and placed on ice prior to visualization by HILO microscopy. Where indicated, vacuoles were incubated in the absence or presence of the fusion inhibitors 3.2 μM Gyp1–46 and 4 μM rGdi. For heat stress or cycloheximide treatment, isolated vacuoles were incubated at 37 °C for 5 min or at 27 °C with 100 µM cycloheximide for 15 min, respectively, prior to adding them to the fusion reaction.
Western blot analysis
For analysis of whole-cell lysates, yeast cells were prepared as previously described76. In brief, extracts were prepared by harvesting yeast cells grown in culture to mid-log phase and washing them once with YPD medium. Cells were then resuspended in fresh YPD and incubated at 30 °C in the presence of 0.2 mM 2-deoxyglucose or 340.6 μM canavanine for times indicated in Fig. 1f, at 30 °C for 90 min for control conditions, at 30 °C in the presence of 100 μM cycloheximide for 120 min, or incubated at 37 °C for 90 min for heat stress. After treatment, 5 OD600nm units of cells were collected, resuspended in 0.5 mL of lysis buffer (0.2 M NaOH, 0.2% β-mercaptoethanol) and incubated on ice for 10 min. Trichloroacetic acid was then added to a final concentration of 5% and samples were incubated on ice for an additional 10 min. Precipitates were collected by centrifugation (12,000 × g for 5 min at 4 °C) and resuspended in 35 μL of dissociation buffer (4% SDS, 0.1 M Tris-HCl, pH 6.8, 4 mM EDTA, 20% glycerol, 2% β-mercaptoethanol and 0.02% bromophenol blue). Tris-HCl, pH 6.8 was then added to a final concentration of 0.3 M and samples were incubated at 37 °C for 10 min. For analysis of in vitro fusion reactions, samples were prepared from isolated vacuoles as previously described37. Whole-cell lysates or isolated vacuole preparations were loaded into 10% SDS-polyacrylamide gels and after electrophoresis separated proteins were transferred to nitrocellulose membranes. Membranes were then probed with antibodies raised against GFP (1:1,000; B2, Santa Cruz Biotechnology Inc., Cat# sc-9996; or Abcam, Cat# ab290), G6PDH (1:1000; Sigma-Aldrich, Cat# A9521) or Pho8 (1:1000; 1D3A10, Abcam, Cat# ab113688). Horseradish peroxidase-labeled affinity purified polyclonal antibodies to either rabbit or mouse (1:10,000; SeraCare, Cat# 5450-0010 or 5450-0011) were used for secondary labeling. Please refer to manufacturer’s website for antibody validation. Chemiluminescence of stained membranes was digitally imaged using a GE Amersham Imager 600.
Data analysis and presentation
Micrographs and movies were processed using ImageJ and Adobe Photoshop CC software. Images shown were adjusted for brightness and contrast, inverted and sharpened with an unsharp masking filter. Linear or 3-dimnesional fluorescence intensity profiles of GFP or FM4–64 fluorescence were generated using ImageJ software. Snapshots from movies were selected to highlight docking and ILF formation during vacuole fusion. Group allocations were blinded for all micrographic analysis.
GFP location measurements shown in Figs. 1e, 2e, 3b, 4b, 7c, d were generated using the ImageJ Cell Counter plugin. Micrographs were quantified by counting the total number of cells, as well as the number of cells where the GFP fluorescence was detected on the plasma membrane (PM), intracellular puncta, the vacuole membrane (Vac mem), or in the vacuole lumen. Values for each cellular GFP localization were normalized to the total number of cells. In Fig. 2g, movies vacuole fusion events in vivo were used to determine the percent of fusion events; Only cells containing two or more vacuoles were counted.
Relative vacuole boundary, lumenal or outside membrane GFP fluorescence values were measured using ImageJ software [see 37]. Prior to quantification, micrographs were background subtracted and a 4 × 4 pixel region of interest was then used to measure the mean GFP fluorescence within the boundary, lumen or on the outer membrane of docked vacuoles only. Single vacuoles or docked vacuoles without a clear outer membrane (i.e., those in large clusters) were excluded. Mean GFP fluorescence intensity was correlated to vacuole size (boundary length, surface area or circumference) by measuring the vacuole diameter (average of two lengthwise measurements) and the length of the boundary membrane. Boundary GFP fluorescence is normalized to that of the outer membrane and lumenal GFP fluorescence is normalized to total fluorescence (boundary, outer membrane and lumen). Only cells containing clearly resolved docked vacuole membranes were used for micrographic analysis.
When applicable, data are reported as cumulative probability plots as well as mean ± S.E.M. Comparisons were calculated using Student two-tailed t-test; P values < 0.05 (*) indicate significant differences. An experiment is defined as a sample prepared from a separate yeast culture on different days. The total number of cells, vacuoles, or boundaries analyzed are indicated. Samples sizes were tested to ensure adequate power using online software (http://www.biomath.info). Variance was assumed to be similar between groups compared. Data was plotted using Synergy KaleidaGraph 4.0 software and figures were prepared using Adobe Illustrator CC software.
Data that support findings of this study are available from the corresponding author upon reasonable request.
Babst, M. MVB vesicle formation: ESCRT-dependent, ESCRT-independent and everything in between. Curr. Opin. Cell Biol. 23, 452–457 (2011).
Katzmann, D. J., Odorizzi, G. & Emr, S. D. Receptor downregulation and multivesicular-body sorting. Nat. Rev. Mol. Cell Biol. 3, 893–905 (2002).
Henne, W. M., Buchkovich, N. J. & Emr, S. D. The ESCRT pathway. Dev. Cell 21, 77–91 (2011).
Palacios, F., Tushir, J. S., Fujita, Y. & D’Souza-Schorey, C. Lysosomal targeting of E-cadherin: a unique mechanism for the down-regulation of cell-cell adhesion during epithelial to mesenchymal transitions. Mol. Cell. Biol. 25, 389–402 (2005).
Rodahl, L. M., Stuffers, S., Lobert, V. H. & Stenmark, H. The role of ESCRT proteins in attenuation of cell signalling. Biochem. Soc. Trans. 37, 137–142 (2009).
Lobert, V. H. & Stenmark, H. Cell polarity and migration: emerging role for the endosomal sorting machinery. Physiology 26, 171–180 (2011).
Zhou, R., Kabra, R., Olson, D. R., Piper, R. C. & Snyder, P. M. Hrs controls sorting of the epithelial Na+ channel between endosomal degradation and recycling pathways. J. Biol. Chem. 285, 30523–30530 (2010).
Traub, L. M. The reverse logic of multivesicular endosomes. EMBO Rep. 11, 79–81 (2010).
Hislop, J. N. & von Zastrow, M. Role of ubiquitination in endocytic trafficking of G-protein-coupled receptors. Traffic 12, 137–148 (2011).
Koumanov, F., Pereira, V. J., Whitley, P. R. & Holman, G. D. GLUT4 traffic through an ESCRT-III-dependent sorting compartment in adipocytes. PLoS One 7, e44141 (2012).
Chassefeyre, R. et al. Regulation of postsynaptic function by the dementia-related ESCRT-III subunit CHMP2B. J. Neurosci. 35, 3155–3173 (2015).
Wang, S., Thibault, G. & Ng, D. T. Routing misfolded proteins through the multivesicular body (MVB) pathway protects against proteotoxicity. J. Biol. Chem. 286, 29376–29387 (2011).
Keener, J. M. & Babst, M. Quality control and substrate-dependent downregulation of the nutrient transporter Fur4. Traffic 14, 412–427 (2013).
Zhao, Y., Macgurn, J. A., Liu, M. & Emr, S. The ART-Rsp5 ubiquitin ligase network comprises a plasma membrane quality control system that protects yeast cells from proteotoxic stress. eLife 2, e00459 (2013).
Blondel, M. O. et al. Direct sorting of the yeast uracil permease to the endosomal system is controlled by uracil binding and Rsp5p-dependent ubiquitylation. Mol. Biol. Cell. 15, 883–895 (2004).
Lewis, M. J. & Pelham, H. R. Inefficient quality control of thermosensitive proteins on the plasma membrane. PLoS One 4, e5038 (2009).
MacGurn, J. A., Hsu, P. C., Smolka, M. B. & Emr, S. D. TORC1 regulates endocytosis via Npr1-mediated phosphoinhibition of a ubiquitin ligase adaptor. Cell 147, 1104–1117 (2011).
Jones, C. B. et al. Regulation of membrane protein degradation by starvation-response pathways. Traffic 13, 468–482 (2012).
MacDonald, C., Stringer, D. K. & Piper, R. C. Sna3 is an Rsp5 adaptor protein that relies on ubiquitination for its MVB sorting. Traffic 13, 586–598 (2012).
Babst, M. Quality control at the plasma membrane: one mechanism does not fit all. J. Cell. Biol. 205, 11–20 (2014).
Nickerson, D. P., West, M., Henry, R. & Odorizzi, G. Regulators of Vps4 ATPase activity at endosomes differentially influence the size and rate of formation of intralumenal vesicles. Mol. Biol. Cell. 21, 1023–1032 (2010).
Hanson, P. I. & Cashikar, A. Multivesicular body morphogenesis. Annu. Rev. Cell. Dev. Biol. 28, 337–362 (2012).
Bowers, K. et al. Degradation of endocytosed epidermal growth factor and virally ubiquitinated major histocompatibility complex class I is independent of mammalian ESCRTII. J. Biol. Chem. 281, 5094–5105 (2006).
Theos, A. C. et al. A lumenal domain-dependent pathway for sorting to intralumenal vesicles of multivesicular endosomes involved in organelle morphogenesis. Dev. Cell. 10, 343–354 (2006).
Leung, K. F., Dacks, J. B. & Field, M. C. Evolution of the multivesicular body ESCRT machinery; retention across the eukaryotic lineage. Traffic 9, 1698–1716 (2008).
Silverman, J. S., Muratore, K. A. & Bangs, J. D. Characterization of the late endosomal ESCRT machinery in Trypanosoma brucei. Traffic 14, 1078–1090 (2013).
Parkinson, M. D. et al. A non-canonical ESCRT pathway, including histidine domain phosphotyrosine phosphatase (HD-PTP), is used for down-regulation of virally ubiquitinated MHC class I. Biochem. J. 471, 79–88 (2015).
Trajkovic, K. et al. Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science 319, 1244–1247 (2008).
Blanc, C. et al. Dictyostelium Tom1 participates to an ancestral ESCRT-0 complex. Traffic 10, 161–171 (2009).
Stuffers, S., Sem Wegner, C., Stenmark, H. & Brech, A. Multivesicular endosome biogenesis in the absence of ESCRTs. Traffic 10, 925–937 (2009).
Edgar, J. R., Eden, E. R. & Futter, C. E. Hrs- and CD63-dependent competing mechanisms make different sized endosomal intraluminal vesicles. Traffic 15, 197–211 (2014).
Katzmann, D. J., Babst, M. & Emr, S. D. Ubiquitin-dependent sorting into the multivesicular body pathway requires the function of a conserved endosomal protein sorting complex, ESCRT-I. Cell 106, 145–155 (2001).
Wang, L., Seeley, E. S., Wickner, W. & Merz, A. J. Vacuole fusion at a ring of vertex docking sites leaves membrane fragments within the organelle. Cell 108, 357–369 (2002).
Wang, L., Merz, A. J., Collins, K. M. & Wickner, W. Hierarchy of protein assembly at the vertex ring domain for yeast vacuole docking and fusion. J. Cell. Biol. 160, 365–374 (2003).
Fratti, R. A., Jun, Y., Merz, A. J., Margolis, N. & Wickner, W. T. Interdependent assembly of specific regulatory lipids and membrane fusion proteins into the vertex ring domain of docked vacuoles. J. Cell. Biol. 167, 1087–1098 (2004).
Mattie, S., McNally, E. K., Karim, M. A., Vali, H. & Brett, C. L. How and why intralumenal membrane fragments form during vacuolar lysosome fusion. Mol. Biol. Cell. 28, 309–321 (2017).
McNally, E. K., Karim, M. A. & Brett, C. L. Selective lysosomal transporter degradation by organelle membrane fusion. Dev. Cell 40, 151–167 (2017).
Beck, T., Schmidt, A. & Hall, M. N. Starvation induces vacuolar targeting and degradation of the tryptophan permease in yeast. J. Cell. Biol. 146, 1227–1238 (1999).
Kawai, K., Moriya, A., Uemura, S. & Abe, F. Functional implications and ubiquitin-dependent degradation of the peptide transporter Ptr2 in Saccharomyces cerevisiae. Eukaryot. Cell 13, 1380–1392 (2014).
Nikko, E. & Pelham, H. R. Arrestin-mediated endocytosis of yeast plasma membrane transporters. Traffic 10, 1856–1867 (2009).
O’Donnell, A. F. et al. 2-Deoxyglucose impairs Saccharomyces cerevisiae growth by stimulating Snf1-regulated and α-arrestin-mediated trafficking of hexose transporters 1 and 3. Mol. Cell. Biol. 35, 939–955 (2015).
Müller, O. et al. Autophagic tubes: vacuolar invaginations involved in lateral membrane sorting and inverse vesicle budding. J. Cell. Biol. 151, 519–528 (2000).
Li, M., Rong, Y., Chuang, Y., Peng, D. & Emr, S. D. Ubiquitin-dependent lysosomal membrane protein sorting and degradation. Mol. Cell 57, 467–478 (2015).
Laplante, M. & Sabatini, D. M. mTOR signaling in growth control and disease. Cell 149, 274–293 (2012).
Brett, C. L. et al. Efficient termination of vacuolar Rab GTPase signaling requires coordinated action by a GAP and a protein kinase. J. Cell. Biol. 182, 1141–1151 (2008).
Merz, A. J. & Wickner, W. T. Resolution of organelle docking and fusion kinetics in a cell-free assay. Proc. Natl Acad. Sci. USA 101, 11548–11553 (2004).
McNally, E. K. & Brett, C. L. ESCRT-independent surface receptor and transporter protein degradation by the ILF pathway. Preprint at https://doi.org/10.1101/167411 (2017).
Velasco, I., Tenreiro, S., Calderon, I. L. & André, B. Saccharomyces cerevisiae Aqr1 is an internal-membrane transporter involved in excretion of amino acids. Eukaryot. Cell 3, 1492–1503 (2004).
Berkower, C., Loayza, D. & Michaelis, S. Metabolic instability and constitutive endocytosis of STE6, the a-factor transporter of Saccharomyces cerevisiae. Mol. Biol. Cell. 5, 1185–1198 (1994).
Egner, R., Mahé, Y., Pandjaitan, R. & Kuchler, K. Endocytosis and vacuolar degradation of the plasma membrane-localized Pdr5 ATP-binding cassette multidrug transporter in Saccharomyces cerevisiae. Mol. Cell. Biol. 15, 5879–5887 (1995).
Shields, S. B. et al. ESCRT ubiquitin-binding domains function cooperatively during MVB cargo sorting. J. Cell. Biol. 185, 213–224 (2009).
Ghaddar, K. et al. Substrate-induced ubiquitylation and endocytosis of yeast amino acid permeases. Mol. Cell. Biol. 34, 4447–4463 (2014).
Hicke, L. & Riezman, H. Ubiquitination of a yeast plasma membrane receptor signals its ligand-stimulated endocytosis. Cell 84, 277–287 (1996).
Haigler, H. T., McKanna, J. A. & Cohen, S. Direct visualization of the binding and internalization of a ferritin conjugate of epidermal growth factor in human carcinoma cells A-431. J. Cell. Biol. 81, 382–395 (1979).
Futter, C. E., Pearse, A., Hewlett, L. J. & Hopkins, C. R. Multivesicular endosomes containing internalized EGF-EGF receptor complexes mature and then fuse directly with lysosomes. J. Cell. Biol. 132, 1011–1023 (1996).
Klumperman, J. & Raposo, G. The complex ultrastructure of the endolysosomal system. Cold Spring Harb. Perspect. Biol. 6, a016857 (2014).
Karim, M. A., Mattie, S. & Brett, C. L. Distinct features of multivesicular body-lysosome fusion revealed by a new cell-free content-mixing assay. Traffic 19, 138–149 (2018).
Hurley, J. H. ESCRT complexes and the biogenesis of multivesicular bodies. Curr. Opin. Cell Biol. 20, 4–11 (2008).
Li, M., Koshi, T. & Emr, S. D. Membrane-anchored ubiquitin ligase complex is required for the turnover of lysosomal membrane proteins. J. Cell. Biol. 211, 639–652 (2015).
Fang, N. N. et al. Rsp5/Nedd4 is the main ubiquitin ligase that targets cytosolic misfolded proteins following heat stress. Nat. Cell Biol. 16, 1227–1237 (2014).
Kümmel, D. & Ungermann, C. Principles of membrane tethering and fusion in endosome and lysosome biogenesis. Curr. Opin. Cell Biol. 29, 61–66 (2014).
Schöneberg, J., Lee, I. H., Iwasa, J. H. & Hurley, J. H. Reverse-topology membrane scission by the ESCRT proteins. Nat. Rev. Mol. Cell Biol. 18, 5–17 (2017).
Huotari, J. & Helenius, A. Endosome maturation. EMBO J. 30, 3481–3500 (2011).
Toshima, J. Y. et al. Spatial dynamics of receptor-mediated endocytic trafficking in budding yeast revealed by using fluorescent alpha-factor derivatives. Proc. Natl Acad. Sci. USA 103, 5793–5798 (2006).
Fagerberg, L., Jonasson, K., von Heijne, G., Uhlén, M. & Berglund, L. Prediction of the human membrane proteome. Proteomics 10, 1141–1149 (2010).
Smith, D. E., Clémençon, B. & Hediger, M. A. Proton-coupled oligopeptide transporter family SLC15: physiological, pharmacological and pathological implications. Mol. Asp. Med. 34, 323–336 (2013).
Chen, L. Q., Cheung, L. S., Feng, L., Tanner, W. & Frommer, W. B. Transport of sugars. Annu. Rev. Biochem. 84, 865–894 (2015).
Schneider, S. Inositol transport proteins. FEBS Lett. 589, 1049–1058 (2015).
Nickerson, D. P., Brett, C. L. & Merz, A. J. Vps-C complexes: gatekeepers of endolysosomal traffic. Curr. Opin. Cell Biol. 21, 543–551 (2009).
Hurley, J. H. ESCRTs are everywhere. EMBO J. 34, 2398–2407 (2015).
Olmos, Y. & Carlton, J. G. The ESCRT machinery: new roles at new holes. Curr. Opin. Cell Biol. 38, 1–11 (2016).
Longtine, M. S. et al. Additional modules for versatile and economical PCR-based gene deletion and modification in Saccharomyces cerevisiae. Yeast 14, 953–961 (1998).
Brett, C. L. & Merz, A. J. Osmotic regulation of Rab-mediated organelle docking. Curr. Biol. 18, 1072–1077 (2008).
Eitzen, G., Will, E., Gallwitz, D., Haas, A. & Wickner, W. Sequential action of two GTPases to promote vacuole docking and fusion. EMBO J. 19, 6713–6720 (2000).
Haas, A., Scheglmann, D., Lazar, T., Gallwitz, D. & Wickner, W. The GTPase Ypt7p of Saccharomyces cerevisiae is required on both partner vacuoles for the homotypic fusion step of vacuole inheritance. EMBO J. 14, 5258–5270 (1995).
Volland, C., Urban-Grimal, D., Géraud, G. & Haguenauer-Tsapis, R. Endocytosis and Degradation of the Yeast Uracil Permease Under Adverse Conditions. J. Biol. Chem. 269, 9833–9841 (1994).
Huh, W.-K. et al. Global analysis of protein localization in budding yeast. Nature 425, 686–691 (2003).
Prosser, D. C., Whitworth, K. & Wendland, B. Quantitative analysis of endocytosis with cytoplasmic pHluorin chimeras. Traffic 11, 1141–1150 (2010).
We thank Beverley Wendland and Derek Prosser for yeast strains. We thank the Canadian Foundation for Innovation and Natural Sciences and Engineering Research Council of Canada for generous support of the Centre for Microscopy and Cellular Imaging at Concordia University. This work was supported by NSERC grants RGPIN/403537-2011 and RGPIN/2017-06652 to C.L.B.
The authors declare no competing interests.
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
McNally, E.K., Brett, C.L. The intralumenal fragment pathway mediates ESCRT-independent surface transporter down-regulation. Nat Commun 9, 5358 (2018). https://doi.org/10.1038/s41467-018-07734-5
This article is cited by
Engineering stem cells to produce exosomes with enhanced bone regeneration effects: an alternative strategy for gene therapy
Journal of Nanobiotechnology (2022)
Biophysical Reviews (2021)
BMC Molecular and Cell Biology (2020)
Cell Communication and Signaling (2020)